ORIC Pharmaceuticals, Inc. (ORIC) Analyst Estimates Quarterly - Discounting Cash Flows

ORIC Pharmaceuticals, Inc. (ORIC) Analyst Estimates Quarterly - Discounting Cash Flows

ORIC Pharmaceuticals, Inc.

ORIC (NASDAQ)

(%)

Financials
ORIC Pharmaceuticals, Inc. Analyst Estimates Quarterly

Annual Quarterly

* (except for per share items) of USD

Period Ending:	2026 12-30	2026 09-30	2026 06-30	2026 03-30	2025 12-30	2025 09-30
Number of Analysts	1234				0	0
Estimated Revenue
Low	1234				0	0
Average	1234				0	0
High	1234				0	0
Estimated EBITDA
Low	1234				0	0
Average	1234				0	0
High	1234				0	0
Estimated EBIT
Low	1234				0	0
Average	1234				0	0
High	1234				0	0
Estimated Net Income
Low	1234				-41.64	-45.96
Average	1234				-36.3	-40.09
High	1234				-33.1	-37.16
Estimated SGA Expenses
Low	1234				0	0
Average	1234				0	0
High	1234				0	0
Estimated EPS
Low	1234				-0.421	-0.464
Average	1234				-0.367	-0.405
High	1234				-0.334	-0.376